Christophe Schilling, PhD

Founder and Former CEO

Geno

Founder of Genomatica (1998), and served as CEO 2009-2024, leading its mission to accelerate the transition to more sustainable materials - creating, scaling and commercializing multiple award-winning technologies delivering measurable impact across the US, Europe, and Asia on an economically competitive basis to fossil fuel based alternatives.  Currently serves as Chairman of the Board of Future Origins - a US-based venture bringing together global consumer brand owners Unilever, Kao, and L'Oreal together with Genomatica-powered technology to build a world-scale alternative supply chain for palm-based home and personal care ingredients.  Additionally, serves as Lead Board Director of Again Bio, an EU-based deep tech company opening the way to enable CO2 as a feedstock for making widely-used chemicals and everyday ingredients, as well as being a member of the Board of Directors at Enduro, an EU-based services and technology provider programming cells to maintain high production to improve large-scale fermentations.
 
Christophe is Chair Emeritus and Board member of Biocom, the largest advocacy organization for California’s life sciences sector, and has served on BIO’s Industrial & Environmental Section Governing Board. He is also a member of YPO, an international leadership organization for chief executives, and previously served on the World Economic Forum Global Agenda Council on Biotechnology.  In 2024 he was named by Forbes as one of the top 50 global sustainability leaders.  Christophe holds a Ph.D. in bioengineering from the University of California, San Diego and earned a B.S. in biomedical engineering from Duke University.